Skip to main content

. 1990 May 5;300(6733):1174–1175. doi: 10.1136/bmj.300.6733.1174

Reversible cardiomyopathy induced by interferon.

M Sonnenblick ¹, D Rosenmann ¹, A Rosin ¹

PMCID: PMC1662916 PMID: 2346805

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Cohen M. C., Huberman M. S., Nesto R. W. Recombinant alpha 2 interferon-related cardiomyopathy. Am J Med. 1988 Oct;85(4):549–551. doi: 10.1016/s0002-9343(88)80094-9. [DOI] [PubMed] [Google Scholar]
Deyton L. R., Walker R. E., Kovacs J. A., Herpin B., Parker M., Masur H., Fauci A. S., Lane H. C. Reversible cardiac dysfunction associated with interferon alfa therapy in AIDS patients with Kaposi's sarcoma. N Engl J Med. 1989 Nov 2;321(18):1246–1249. doi: 10.1056/NEJM198911023211806. [DOI] [PubMed] [Google Scholar]
Dickson D. Deaths halt interferon trials in France. Science. 1982 Nov 19;218(4574):772–772. doi: 10.1126/science.6182613. [DOI] [PubMed] [Google Scholar]
Quesada J. R., Reuben J., Manning J. T., Hersh E. M., Gutterman J. U. Alpha interferon for induction of remission in hairy-cell leukemia. N Engl J Med. 1984 Jan 5;310(1):15–18. doi: 10.1056/NEJM198401053100104. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES